Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin crossover trial in pediatric homozygous familial hypercholesterolemia
NL-OMON41938Phase 3Active, not recruiting
- Sponsor
- AstraZeneca
- Start
- Nov 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of rosuvastatin in homozygous familial hypercholesterolemia (HoFH) (2 arms), sponsored by AstraZeneca. Started Nov 2014; status: active, not recruiting.
02
Drugs
rosuvastatin
03
Conditions
homozygous familial hypercholesterolemia (HoFH)
Beyond the preview
Go deeper on NL-OMON41938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41938.